— Know what they know.
Not Investment Advice

IRWD NASDAQ

Ironwood Pharmaceuticals, Inc.
1W: -11.9% 1M: -17.5% 3M: -16.9% YTD: -14.8% 1Y: +149.3% 3Y: -62.2% 5Y: -72.9%
$3.64
-0.12 (-3.19%)
 
Weekly Expected Move ±6.3%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 37 · $599.2M mcap · 158M float · 1.38% daily turnover · Short 51% of daily vol

📊 Key Metrics

TTM
$389M
Revenue
+26.2% YoY
$130M
Net Income
+1747.0% YoY
$186M
Free Cash Flow
+519.8% YoY
100.0%
Gross Margin
70.2%
Op. Margin
45.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-55.3%
ROA41.4%
ROIC93.9%

Valuation

P/E4.6
P/B-3.7
EV/EBITDA4.2

Leverage

Debt/Equity-2.45
Current Ratio6.06
Interest Cov.7.3x

Quality Scores

Piotroski F7/9
Altman Z-1.99
Beneish M-3.24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms